Soleno Therapeutics Inc. buy Wells Fargo & Company
Start price
27.02.26
/
50%
€32.80
Target price
27.02.27
€93.24
Performance (%)
37.20%
Price
28.04.26
?
Summary
This prediction is currently active. With a performance of 37.20% the BUY prediction by Wells_Fargo___Compan is a big success. This prediction currently runs until 27.02.27. The prediction end date can be changed by Wells_Fargo___Compan at any time. Wells_Fargo___Compan has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Soleno Therapeutics Inc. | -0.402% | -0.402% |
| iShares Core DAX® | -1,42 % | 8,92 % |
| iShares Nasdaq 100 | 3,27 % | 16,28 % |
| iShares Nikkei 225® | 1,75 % | 16,24 % |
| iShares S&P 500 | 1,45 % | 10,91 % |
Comments by Wells_Fargo___Compan for this prediction
In the thread Soleno Therapeutics Inc. diskutieren
Soleno Therapeutics (SLNO) had its price target lowered by Wells Fargo & Company from $114.00 to $110.00. They now have an "overweight" rating on the stock.
Ratings data for SLNO provided by MarketBeat
Stopped prediction by Wells_Fargo___Compan for Soleno Therapeutics Inc.
Soleno Therapeutics Inc.
Start price
Target price
Perf. (%)
€57.65
20.08.25
20.08.25
€105.76
20.08.26
20.08.26
-21.94%
28.04.26
28.04.26
